Skip to main content
. 2012 Jun 30;1(3):cvd.2012.012010. doi: 10.1258/cvd.2012.012010

Table 1.

Profile of risk factors in young CAD patients and young control population

CAD group (n = 292) Control group (n = 92) P value OR (95% CI)
Age (years ±SD) 36.3 ± 4.11 35.6 ± 3.26 0.1737
Smokers* 217 (74.3) 13 (14.1) <0.0001 17.6 (9.2–33.4)
Smoking index* Range 0–1500 Range 0–600 <0.0001
Median 120 Median 0
IQ range 300 IQ range 0
Hypertension* 73 (25.0) 12 (13.0) 0.0235 2.2 (1.14–4.31)
Family history of premature CAD 88 (30.1) 25 (27.1) 0.6799 1.16 (0.69–1.95)
Diabetes mellitus 43 (14.7) 7 (7.6) 0.1115 2.10 (0.91–4.84)
Prediabetes 16 (5.4) 4 (4.3) 0.8753 1.28 (0.42–3.92)
Central obesity* 113/236 (47.7) 27/83 (32.5) 0.0217 1.91 (1.13–3.22)
Premature arcus* 47 (16.1) 1 (1.1) 0.0003 17.46 (2.37–128.39)
Premature balding* 65 (22.3) 2 (2.2) <0.0001 12.89 (3.09–53.74)
Premature greying* 102 (34.9) 11 (11.9) <0.0001 3.95 (2.01–7.76)
Dyslipidaemia 172/189 (91.0) 73/83 (87.9) 0.5787 1.39 (0.61–3.17)
High total cholesterol 36/189 (19.0) 17/83 (20.5) 0.9134 0.91 (0.48–1.74)
Low HDL-C 122/177 (68.9) 47/79 (59.5) 0.1838 1.51 (0.97–2.62)
High triglycerides* 81/185 (43.8) 19/82 (23.2) 0.0021 2.58 (1.43–4.66)
High LDL-C 73/ 173 (42.2) 28/80 (35.0) 0.3427 1.36 (0.78–2.35)
Mean carotid intima media thickness (mm)* (n = 111) 0.62 ± 0.12 (n = 74) 0.54 ± 0.08 <0.0001
Increased CIMT (>0.80 mm)* 11 (9.9) 1(1.1) 0.3447 3.56 (0.46–27.97)
Plaque* 13/111 (11.7) 0/74 (0.0) 0.0058

IQ, interquartile

Figures in parentheses denote percentages

*P < 0.05